---
layout: post
title: "Patient Engagement Advisory Committee; Notice of Meeting"
date: 2026-02-05 18:58:49 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-08013
original_published: 2022-04-14 00:00:00 +0000
significance: 8.00
---

# Patient Engagement Advisory Committee; Notice of Meeting

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** April 14, 2022 00:00 UTC
**Document Number:** 2022-08013

## Summary

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the CDRH Patient Engagement Advisory Committee. The general function of the committee is to provide advice to the Commissioner of Food and Drugs, or designee, on complex scientific issues relating to medical devices, the regulation of devices, and their use by patients. The meeting will be open to the public.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/04/14/2022-08013/patient-engagement-advisory-committee-notice-of-meeting)
- API: https://www.federalregister.gov/api/v1/documents/2022-08013

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
